In the multivariate model ( Table 2) , after adjusting for all factors found to have PϽ.10 in the univariate analysis as well as age and sex, we found that the number of research publications, the number of volunteer experiences, and possession of an advanced degree in addition to a medical degree were significantly associated with a current career in academia. Graduates in the academic group published an average of 5.2 articles per person at the time of application compared with 1.9 articles per person in the nonacademic group.
Photodynamic Therapy for Tumors on the Eyelid Margins
T he eyelids are prone to basal cell carcinomas (BCCs) and papillomas. 1 Cryotherapy, surgical excision, and radiotherapy have limitations related to their complexity and to the resulting functional deficiencies (eg, lagophthalmos or epiphora) and unsatisfying cosmesis. 2 New treatment techniques for eyelid tumors are therefore desirable.
Photodynamic therapy (PDT) with topical methyl aminolevulinate (Metvix cream, 16%; Photocure ASA, Oslo, Norway) is a safe and effective noninvasive treatment of BCCs that causes minimal damage to surrounding tissue and results in excellent cosmetic outcomes. 3 However, PDT is not normally used to treat eyelid lesions owing to the risk of phototoxic eye damage. We describe The ocular shield is removed after illumination and replaced with a protective eye patch for 24 hours to protect from ambient light. Eye drops (chloramphenicol, 5%, and dexamethasone, 1%) are used daily for 3 days to prevent infection and irritation of the eye. After 1 week, crusts are removed, and the procedure is repeated (Figure, D) .
Results. We used PDT to treat 12 patients with histologically verified eyelid BCC and papillomas (Table) . Median complete response time was 8 months for 9 of the patients (range, 5-21 months), yielding a response rate of 75%. In 3 patients, however, the tumor recurred after a median of 4 months (range, 0-21 months). In all cases, functional and cosmetic outcomes were highly satisfying, and treatment-related pain was acceptable thanks to the anesthesia. Comment. Our patients' tumors were located primarily on the eyelid margin or rima palpebrarum, locations that make tumor debulking a challenge because of the soft base and tumor tissue involving the eyelashes. This might explain the poorer response rate for BCCs at this location, and more than 2 PDT sessions might be required for some of these tumors. However, our rate was more favorable than that found in a previous study, 4 which treated eyelid and periocular BCCs with laser-mediated PDT and 5-aminolevulinate, achieving complete response in only 42% of cases. 4 Six of our patients had already undergone surgery prior to referral to us but experienced recurrence, clearly less favorable outcomes than those achieved by PDT.
To our knowledge, the use of conventional PDT techniques solely for treatment of tumors on the eyelid margins has not previously been described. Our cases may expand the use of PDT for these difficult-to-treat tumors.
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Searching the LILACS Database
Could Improve Systematic Reviews in Dermatology W ell-performed systematic reviews should analyze as many articles as possible to provide the best evidence available. However, some reviews limit their searches only to a few numbers of databases, mainly literature in English, published in journals fundamentally edited in developed countries. 1 The LILACS database is an underused source of trials that indexes journals mainly from Latin American and Caribbean countries. 2 In the present study, I sought to assess whether including a LILACS search improved the quality of systematic reviews in dermatology. . The first group of reviews was retrieved from the Cochrane Skin Group Web site, 3 and the non-Cochrane reviews were found through a search in Medline, according to the strategy described by Montori et al. 4 A systematic review was defined as a study that used any systematic way of searching the literature using explicit criteria for article selection.
Methods. I evaluated reviews from the Cochrane Skin
For the included reviews, we used LILACS to locate randomized clinical trials that matched each review's inclusion criteria using a validated, highly sensitive LILACS search strategy described elsewhere. 1 The LILACS search result was classified positive when at least 1 randomized controlled trial that fit the inclusion criteria was found and negative when no such trials were located. The search results were considered inconclusive when at least 1 trial that fit the inclusion criteria was found but it could not be sorted as a randomized one. For the positive LILACS search results, the references listed in the review were checked to determine if the identified articles had already been located.
Results.
A total of 44 reviews (25 Cochrane and 19 nonCochrane) were analyzed. Three of the Cochrane reviews included a LILACS search and were excluded from further analysis (Table and eTable [http://www .archdermatol.com]). Twenty percent of the reviews (8 of 41) were restricted to English-language articles and 51% (21 of 41) explicitly had no language restriction.
The LILACS search results were positive in 29% of all reviews (12 of 41), inconclusive in 34% (14 of 41), and negative in 37% (15 of 41). In 5 of the 14 inconclusive cases, the original review allowed any kind of trial as inclusion criteria. In Cochrane reviews, 18% of the search results were positive (4 of 22), whereas in the nonCochrane reviews 42% were positive (8 of 19). On the other hand, 27% (6 of 22) and 42% (8 of 19), respectively, produced inconclusive results (references available from the author).
Among the 12 reviews with positive LILACS search results (4 Cochrane and 8 non-Cochrane), only 1 Cochrane review had located the article identified on LILACS by other methods. Therefore, in 27% of the systematic reviews (11 of 41), a LILACS search was effective in identifying new articles suitable for inclusion and not located by the authors.
In conclusion, using LILACS can increase the number of trials potentially suited for inclusion in systematic reviews. 
